n-glycolylneuraminic acid has been researched along with Ebola Hemorrhagic Fever in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bach, JM; Conchon, S; Duchi, R; Duvaux, O; Evanno, G; Galli, C; Jacquot, F; Judor, JP; Lagutina, I; Lazzari, G; Le Berre, L; Lheriteau, E; Mai, HL; Martinet, B; Perota, A; Perreault, H; Raoul, H; Reynard, O; Salama, A; Soulillou, JP; Volchkov, V | 1 |
1 other study(ies) available for n-glycolylneuraminic acid and Ebola Hemorrhagic Fever
Article | Year |
---|---|
Anti-EBOV GP IgGs Lacking α1-3-Galactose and Neu5Gc Prolong Survival and Decrease Blood Viral Load in EBOV-Infected Guinea Pigs.
Topics: Animals; Antibodies, Anti-Idiotypic; Antibodies, Viral; Ebola Vaccines; Ebolavirus; Galactose; Guinea Pigs; Hemorrhagic Fever, Ebola; Immunoglobulin G; Male; Neuraminic Acids; Swine; Vaccination; Viral Envelope Proteins; Viral Load | 2016 |